Washington Trust Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Washington Trust Advisors's PFE Position: Q2 2026 in Review
Washington Trust Advisors reduced its Pfizer (PFE) stake by 4.1% in Q2 2026, selling an estimated $49.1K and leaving 43,407 shares worth $1.05M. The position accounts for 0.08% of the portfolio, ranked #114.
Washington Trust Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.2M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Washington Trust Advisors held 43,407 shares of Pfizer worth $1.05M as of Q2 2026.
- Washington Trust Advisors sold 1,876 Pfizer shares in Q2 2026, an estimated $49.1K.
- Pfizer made up 0.08% of Washington Trust Advisors's portfolio in Q2 2026, its #114 holding.
- Washington Trust Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Washington Trust Advisors's Pfizer position peaked at $3.2M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.